Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis & Trends - Industry Forecast to 2030

Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis & Trends - Industry Forecast to 2030

The Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $386.6 billion by 2030. Some of the prominent trends that the market is witnessing includeincreasing focus on pre-clinical development services in contract manufacturing organization (CMO), rising healthcare standards in developing countries and expensive breakthrough therapies and increasing number of small & medium sized companies with CDMO facilities.

Based on type, the market is bifurcated into contract manufacturing organization (CMO) and contract research organization (CRO). The contract manufacturing organization (CMO) segment is further sub-segmented into active pharmaceutical (API) and finished dosage formulations (FDF). Active pharmaceutical (API) is sub divided into branded API manufacturing and generic API manufacturing. Finished dosage formulations (FDF) further sub-segmented called oral liquids. Contract research organization (CRO) segment is further divided into clinical trial, data management services, consulting services, laboratory services.

On the basis of research phase, the market is classified intophase I, phase II, phase III, phase IV, and pre-clinical.

On the contrary to the category, the market is segmented into pharmaceutical industry and biopharmaceutical industry.

By therapeutic application, the market is fragmented into pulmonary disorders, infectious diseases, metabolic disorders, cardiovascular disorders, central nervous system, oncology and gastrointestinal disorders.

Based on service type, the market is bifurcated into pharmaceutical manufacturing services, biologics manufacturing services and drug development services. Pharmaceutical manufacturing services are segregated into secondary packaging, pharmaceutical finished dosage formulation (FDF) development and manufacturing, and pharmaceutical active pharmaceutical ingredient (API) manufacturing. Pharmaceutical finished dosage formulation (FDF) development and manufacturing is divided into liquid dose formulation, capsule manufacturing services, parenteral/injectable dose formulation, tablet manufacturing services and solid dose formulation. Biologics manufacturing services is further categorized into biologics active pharmaceutical ingredient (API) manufacturing and biologics finished dosage formulation (FDF) manufacturing.

Based on end user, the market is divided into academic institutes, medical device companies,generic pharmaceutical and biopharmaceutical companies, big pharma, and small & mid-size pharma.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2022, 2023 revenue estimations are presented for 2024 and forecasts from 2025 till 2030. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia Pacific

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- South Africa
- Others

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2030, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2030
- Market opportunities and recommendations for new investments